CAS NO: | 320367-13-3 |
包装 | 价格(元) |
1mg | 电议 |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
生物活性 | Lixisenatide is aglucagon-like peptide-1 (GLP-1) receptoragonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). | ||||||||||||||||
IC50& Target | GLP-1 receptor[1][2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 4858.49 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C215H347N61O65S | ||||||||||||||||
CAS 号 | 320367-13-3 | ||||||||||||||||
Sequence Shortening | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 106 mg/mL(21.82 mM;Need ultrasonic and warming) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |